1 year return (CAGR)
482.68%
Neurosense Therapeutics Ltd Exchange (NASDAQ, USD)
NRSN
7.40
+0.22 (+3.06%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
107.94%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
279.47M
Price/Sales
-
Ent value
281.89M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
11.06%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 7.35 |
| Daily high | 7.40 |
| Daily low | 6.80 |
| Daily Volume | 9K |
| All-time high | 8.02 |
| 1y analyst estimate | 6.50 |
| Beta | 1.58 |
| EPS (TTM) | -0.20 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NRSN | S&P500 | |
| Current price drop from All-time high | -7.73% | -1.29% |
| Highest price drop | -94.38% | -56.47% |
| Date of highest drop | 20 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -76.16% | -10.68% |
| Avg time to new high | 240 days | 12 days |
| Max time to new high | 1121 days | 1805 days |
News
